Clinical Trial Update: Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacokinetics, acceptability, and safety of famciclovir in infants aged 1 month to less than 12 months with herpes simplex infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection

Drugs mentioned

• Famciclovir (Famvir) (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Herpes Simplex | Phase 2 | Status: COMPLETED | Results posted: 2010-12-14